Member Info for Hotfinance14

Am i correct in stating once the deadline for questions has gone you can no longer view your questions as I cannot see my questions on the dashboard this morning ?

'It's all coming together nicely. MSC, Quadrise, Cargill, MAC2, possibly others, all working collaboratively (no 'us and them' in this) to get everything in place to make the trial and subsequent move to commercial supplies a success.'

SC..You said the same thing 12 months ago ol boy.

Please note the deadline for the IMC questions :

Questions can be pre-submitted until 25 Mar 2026, 09:00 GMT. Whilst the Company may not be in a position to answer every question it receives, it will address the most prominent within the confines of information already disclosed to the market.

AKHM..We had 'soon' by AM about 9 months ago and by Peter 2 months ago.

The reason for the increase in assets is due to the 'cash and cash equivalents' figures. The December 2024 was £3m lower than that at December 2025. The December 2024 figure was only £1m and thus the fund raise early 2025.

Proactive summary of interims ?

QED - QUADRISE PLC

7:00: Interim Results & Notice of Investor Presentation

Quadrise posted an H1 FY26 loss after tax of £2.0m (H1 FY25: £1.7m), cash £4.0m at 31 Dec 2025 (vs £1.4m), total assets £8.3m, basic loss per share 0.10p, with production & development costs £1.0m and admin £0.9m; directors say current cash should cover planned trials but further funding may be required and auditors have previously flagged a going‑concern uncertainty. Commercial catalysts include an imminent MSC/Cargill vessel trial at MAC² Antwerp (PoC then ~4,000‑hour bioMSAR LONO), Valkor’s 500 bpd Utah pilot expected Q4 2026 (staged payments US$1.0m to Jun 2026), an OCP Morocco trial plan expected Q2 2026, Panama permitting underway, and progress on multiple biofeedstock pathways and AI digitisation—management prioritises finalising trial legal frameworks, feedstock and shipowner agreements to drive commercialisation in 2026, while geopolitical, regulatory and execution risks could delay progress.

At 30th June 2025 cash was £5.9m and at 31st Dec 2025 it was £4m. That is a cashburn of £320k per month with most of this being spent on salaries and no major project costs. Excluding any further Valkor income the company will run out of cash at the end of this year.

Interims announced today as expected. Vince was spot on with his prediction. Nothing seems to have progressed.

Davidshipping..When you do your weekly food shop do you by any chance explain to the cashier about averaging down ?

'Valkor payment due on wednesday'. I thought it was due by the end of March.

The Orns..Peter said this at the AGM :

“Having two trials up and running in two months was not the plan; however, we are working to secure agreements covering the MSC trial and one other within the next two months.”

The SP is now a staggering 60% lower from when our new CEO started his tenure.As we know there will be no material news with the interim results so this does not bode well.

Enjoy the football at the weekend.

Davidshippijg..As i have stated it is next week. This is a fact not an opinion.

As i have been stating we have a presentation next week so this means the interims are next week.

The middle east war will have no impact on Quadrise. We have been here before.

Thew presentation next week will show where we are in the projects.

Good spot JackG. We should get more info from the presentation next week.

From Proactive

https://www.proactiveinvestors.co.uk/companies/news/1089134/quadrise-adds-michael-covington-to-board-as-non-exec-director-1089134.html

New NON-Exec added to the team. It states :

"We are delighted to welcome Michael to Quadrise. With more than three decades of experience across clean-energy, alternative fuels, infrastructure and industrial technology, he brings exceptional financial, strategic and governance expertise to the Company. His extensive background in strategic capital, complex deal structuring and supporting organisations through commercial scale‑up, together with his deep understanding of the energy transition and major industrial counterparties, aligns strongly with our ambitions as Quadrise enters its next phase of growth and commercialisation."

I think the next phase is to start these trials

. 'No trials no need for a commercial officer role.'

AKHM..Exactly. They had a role as a COO when we do not even have trial start dates.Madness.

So we can conclude the chief commercial officer role no longer exists but we have the new role of Business development manager. In my book that is a step backwards in progress.